Diabetics can be identified in an electronic medical record using laboratory tests and prescriptions

Journal of Clinical Epidemiology

Volumn 64, Issue 4, 2011, Pages 431-435

  Tu, Karen ^a,b,c   Manuel, Doug ^a,d,e   Lam, Kelvin ^a   Kavanagh, Doug ^a   Mitiku, Tezeta F ^a   Guo, Helen ^a  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Administrative data; Diabetes; Electronic medical records

Indexed keywords

ANTIDIABETIC AGENT;

ACCURACY; ARTICLE; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; GLUCOSE BLOOD LEVEL; HEALTH CARE QUALITY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADULT; DIABETES MELLITUS; DOCUMENTATION; DRUG PRESCRIPTIONS; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; ONTARIO; PATIENT CARE; QUALITY OF HEALTH CARE; SENSITIVITY AND SPECIFICITY;

EID: 79951949481     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2010.04.007     Document Type: Article

References (13)

1. Public Health Agency of Canada. Report from the national diabetes surveillance system: diabetes in Canada, 2008 13-11-2008.
2. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-6. (Pubitemid 41103345)
3. National Physician Survey. National results by FP/GP or other specialist, sex, age and ll physicians. The College of Family Physicians of Canada, Canadian Medical Association, The Royal College of Physicians and Surgeons of Canada: 2007. Available at http://www.nationalphysiciansurvey.ca/nps/2007- Survey/2007nps-e.asp. Accessed June 17, 2009.
4. Mitiku T, Tu K. Using data from electronic medical records: theory versus practice. Healthc Q 2008;11:23-5.
5. Institute for Clinical Evaluative Sciences. Privacy code: protecting personal health information at ICES. http://www.ices.on.ca/file/ ICES%20Privacy%20Code%20Version%204.pdf. Accessed June 17, 2009.
6. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(Suppl 1):S1-S201.
7. Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006;368:1096-105.
8. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
9. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-66. (Pubitemid 46220816)
10. Hassey A, Gerrett D, Wilson A. A survey of validity and utility of electronic patient records in a general practice. BMJ 2001;322: 1401-5. (Pubitemid 32523297)
11. Van Staa TP, Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 1994;3:15-21.
12. Crane HM, Kadane JB, Crane PK, Kitahata MM. Diabetes case identification methods applied to electronic medical record systems: their use in HIV-infected patients. Curr HIV Res 2006;4:97-106.
13. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004;57: 131-41. (Pubitemid 38668607)